Douglas Pharmaceuticals Executive and Leadership Team

Sean Westbrook, the Chief Executive Officer at Douglas Pharmaceuticals, directs the company's overall strategic vision and operational execution. Westbrook guides the organization's expansion into new international markets, building upon the company's history of moving from distribution to independent research and development. The Chief Executive Officer ensures alignment across all departments, fostering a culture of innovation that supports the company's mission to provide essential pharmaceutical products globally. This leadership role involves overseeing financial performance, driving long-term growth initiatives, and maintaining strong relationships with stakeholders. Westbrook's strategic direction is crucial for navigating the complex pharmaceutical landscape and solidifying Douglas Pharmaceuticals' position as a key player in the industry. The Chief Executive Officer's focus remains on sustainable development and enhancing the company's research capabilities to meet evolving healthcare needs worldwide.

Rod De Spong, the Chief Operating Officer at Douglas Pharmaceuticals, manages the day-to-day operational activities and ensures efficient production processes. De Spong oversees the manufacturing facilities, implementing best practices to maintain high standards of quality and compliance in pharmaceutical production. This role is critical for scaling operations to meet increasing export demands, a key growth area for the company. The Chief Operating Officer works closely with the supply chain and research teams to streamline workflows from development to distribution. De Spong's leadership ensures that manufacturing capabilities effectively support the company's research and development pipeline, translating scientific advancements into tangible pharmaceutical products. By optimizing resource allocation and operational efficiency, the Chief Operating Officer directly contributes to the company's ability to deliver reliable medicines across New Zealand and international markets.

Brent Limmer, the Chief Marketing Officer & Coordinator (Contract Manufacturing ) at Douglas Pharmaceuticals, spearheads market penetration strategies and manages client relationships for contract manufacturing services. Limmer drives the commercialization of pharmaceutical products, identifying new market opportunities and developing targeted campaigns to expand the company's global reach. This dual role involves coordinating production schedules and client requirements for contract manufacturing, ensuring seamless delivery of services. The Chief Marketing Officer & Coordinator (Contract Manufacturing ) works to enhance brand visibility and establish Douglas Pharmaceuticals as a preferred partner for pharmaceutical development and production. Limmer's expertise in market dynamics and contract operations is vital for securing new business and fostering long-term partnerships. By focusing on both market expansion and operational coordination, Brent Limmer ensures the company's commercial success and manufacturing agility.

Trent Barclay, the Manager, Supply Planning & Chief Marketing Officer, Consumer at Douglas Pharmaceuticals, orchestrates the planning and execution of consumer product marketing initiatives alongside supply chain optimization. Barclay ensures that the supply chain effectively supports the demand generated by consumer-focused marketing campaigns, managing inventory levels and distribution logistics. This leadership position is key to aligning product availability with market needs, particularly for the company's export markets. The Manager, Supply Planning & Chief Marketing Officer, Consumer drives brand awareness and sales growth for consumer pharmaceutical products through strategic marketing efforts. Barclay's integrated approach bridges the gap between market demand and operational capacity, ensuring timely delivery of high-quality products to consumers. This dual focus allows Trent Barclay to maximize market opportunities while maintaining efficient operational flow.

Ceri Rowland, the Chief People Officer at Douglas Pharmaceuticals, leads human resources strategy and talent management to support the company's growth and innovation objectives. Rowland cultivates a positive and productive work environment, ensuring that the organization attracts, develops, and retains skilled professionals across all functions, from research to manufacturing. This role is fundamental to building a strong corporate culture that underpins the company's commitment to quality and scientific advancement. The Chief People Officer oversees employee relations, compensation and benefits, and organizational development initiatives. Ceri Rowland's focus on people empowers the workforce to drive the company's mission forward, fostering collaboration and expertise essential for pharmaceutical development and export. By prioritizing human capital, Rowland ensures Douglas Pharmaceuticals has the talent necessary to succeed in the global pharmaceutical industry.